Michal A. Miller

415 total citations
15 papers, 298 citations indexed

About

Michal A. Miller is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michal A. Miller has authored 15 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michal A. Miller's work include Neuroblastoma Research and Treatments (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cell death mechanisms and regulation (3 papers). Michal A. Miller is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cell death mechanisms and regulation (3 papers). Michal A. Miller collaborates with scholars based in United States, United Kingdom and Japan. Michal A. Miller's co-authors include Anthony D. Sandler, David L. Scott, Roma Maguire, Nora Kearney, Lisa McCann, Xiaoyan Zhu, Arthur Μ. Krieg, Annette J. Schlueter, Xiaoyan Zhu and Thomas S. Griffith and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

Michal A. Miller

14 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal A. Miller United States 8 109 102 92 41 35 15 298
Brian Flaherty United States 8 53 0.5× 247 2.4× 281 3.1× 43 1.0× 18 0.5× 26 484
Katherine Tkaczuk United States 9 105 1.0× 161 1.6× 17 0.2× 52 1.3× 32 0.9× 18 326
Tianhui He China 10 107 1.0× 180 1.8× 140 1.5× 14 0.3× 11 0.3× 28 417
Zixi Hong China 6 94 0.9× 79 0.8× 36 0.4× 88 2.1× 20 0.6× 7 336
Maribel Tírado-Gómez Puerto Rico 11 226 2.1× 114 1.1× 21 0.2× 11 0.3× 36 1.0× 35 404
Charlene M. McShane United Kingdom 9 85 0.8× 67 0.7× 37 0.4× 10 0.2× 19 0.5× 27 326
Laura Longo Italy 10 44 0.4× 42 0.4× 31 0.3× 41 1.0× 41 1.2× 27 377
Huijing Wu China 9 69 0.6× 56 0.5× 23 0.3× 19 0.5× 8 0.2× 25 274
Scott A. Soefje United States 8 71 0.7× 139 1.4× 53 0.6× 4 0.1× 14 0.4× 29 369
Jelena Lazić Serbia 11 68 0.6× 57 0.6× 22 0.2× 11 0.3× 88 2.5× 36 248

Countries citing papers authored by Michal A. Miller

Since Specialization
Citations

This map shows the geographic impact of Michal A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal A. Miller more than expected).

Fields of papers citing papers by Michal A. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal A. Miller. The network helps show where Michal A. Miller may publish in the future.

Co-authorship network of co-authors of Michal A. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Michal A. Miller. A scholar is included among the top collaborators of Michal A. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal A. Miller. Michal A. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Miller, Michal A., Daniel C. Hughes, Darpan I. Patel, et al.. (2025). Balance Changes in Adult Cancer Survivors Participating in a 16-Week Therapeutic Yoga Program. Integrative Cancer Therapies. 24. 1573628184–1573628184.
2.
Miller, Michal A., et al.. (2020). Management of Refractory Menstrual Bleeding in an Adolescent with Glanzmann Thrombasthenia: A Case Report and Review. Case Reports in Obstetrics and Gynecology. 2020(1). 8848763–8848763. 2 indexed citations
3.
Agrawal, Vaibhav, et al.. (2018). Assessing perceptions of transition readiness in the adolescent and young adult oncology population.. Journal of Clinical Oncology. 36(7_suppl). 73–73. 1 indexed citations
4.
Lim, Peter Paul, et al.. (2017). A Rare Initial Presentation of Primary Diffuse Leptomeningeal PNET in a 10-Year-Old-Male.. PubMed. 70(12). 543–545. 2 indexed citations
5.
Maguire, Roma, Lisa McCann, Michal A. Miller, & Nora Kearney. (2008). Nurse's perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS©) to monitor and manage chemotherapy-related toxicity. European Journal of Oncology Nursing. 12(4). 380–386. 69 indexed citations
6.
Miller, Michal A., Kensuke Ohashi, Xiaoyan Zhu, et al.. (2006). Survivin mRNA Levels Are Associated With Biology of Disease and Patient Survival in Neuroblastoma: A Report From the Children's Oncology Group. Journal of Pediatric Hematology/Oncology. 28(7). 412–417. 25 indexed citations
7.
Azuhata, Takeo, David L. Scott, Thomas S. Griffith, Michal A. Miller, & Anthony D. Sandler. (2006). Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. Journal of Pediatric Surgery. 41(8). 1431–1440. 28 indexed citations
9.
Miller, Michal A., Bahri Karaçay, Xiaoyan Zhu, M. Sue O’Dorisio, & Anthony D. Sandler. (2005). Caspase 8L, a novel inhibitory isoform of caspase 8, is associated with undifferentiated neuroblastoma. APOPTOSIS. 11(1). 15–24. 30 indexed citations
10.
Miller, Michal A. & Anthony D. Sandler. (2005). Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma. Journal of Pediatric Surgery. 40(5). e17–e19. 16 indexed citations
11.
Miller, Michal A. & Annette J. Schlueter. (2004). Transfusions via hand‐held syringes and small‐gauge needles as risk factors for hyperkalemia. Transfusion. 44(3). 373–381. 21 indexed citations
12.
Sandler, Anthony D., et al.. (2003). CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.. PubMed. 63(2). 394–9. 88 indexed citations
13.
Miller, Michal A.. (2001). Enrollment Begins for Largest-Ever Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 93(15). 1132–1132. 8 indexed citations
14.
Miller, Michal A.. (2000). NCI Monograph Links Secondhand Smoke to Cancer and Other Diseases. JNCI Journal of the National Cancer Institute. 92(1). 14–14. 1 indexed citations
15.
Miller, Michal A.. (1999). PSA as a Treatment Marker for Prostate Cancer?. JNCI Journal of the National Cancer Institute. 91(13). 1108–1110. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026